Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,616 datasets
255 acute myocardial infarction patients were profiled for hemostatic parameters to study coronary blood flow patency. The dataset, authored by Anna Kalinskaya and last updated in 2026, includes 169 patients with impaired coronary flow and 86 with preserved flow. Results identified associations between clot formation, platelet function, and fibrinolysis measures and both in-hospital and out-of-hospital complications.
Data from a study by Reyisha Taximaimaiti, published on figshare in 2026, investigating gait-based biomarkers to differentiate the parkinsonian subtype of multiple system atrophy (MSA-P) from Parkinson's disease. The dataset includes gait parameters from 74 PD patients, 33 MSA-P patients, and 79 healthy controls, collected using a three-dimensional motion capture system during timed up and go, cognitive load, and endogenous beat tests.
A nationwide cohort of 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France between February 2020 and June 2021. The data was collected by Santé publique France and analyzed by Antoine Journé to investigate factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support. The study stratifies patients by age group (<45, 45–64, ≥65 years) and the first three pandemic periods.
A nationwide cohort of 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France between February 2020 and June 2021. The data, managed by Santé publique France, was used to investigate factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support. The study was authored by Antoine Journé and last updated in April 2026.
From February 2020 to June 2021, this nationwide cohort study analyzes 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France. It investigates factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support, stratified by age and pandemic period. The dataset was created by Antoine Journé and is shared under a CC-BY-4.0 license.
15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France between February 2020 and June 2021. This nationwide cohort study from Santé publique France investigates factors like age, sex, and obesity associated with mortality, severe ARDS, and use of invasive respiratory support across the first three pandemic periods. The dataset was authored by Antoine Journé and last updated in April 2026.
A nationwide cohort of 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France. The data was collected by Santé publique France and analyzed by Antoine Journé to investigate factors associated with mortality, severe ARDS, and need for invasive respiratory support across the first three pandemic periods. The dataset was last updated on April 23, 2026.
February 2020 to June 2021 data from a nationwide cohort of 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France. The dataset, created by Antoine Journé and shared under CC-BY-4.0, investigates factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support across three pandemic periods and different age groups.
A nationwide cohort of 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France between February 2020 and June 2021. The data, managed by Santé publique France, was used to investigate factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support. The study was authored by Antoine Journé and published on figshare.
Antoine Journé's nationwide cohort study analyzes 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France. The data, last updated in April 2026, investigates factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support across the first three pandemic periods. The study stratifies analyses by age groups and identifies associations with obesity and male sex.
15,423 critically ill COVID-19 patients admitted to intensive care in mainland France between February 2020 and June 2021. This nationwide cohort study by Antoine Journé investigates factors like obesity and male sex associated with mortality, severe ARDS, and need for invasive respiratory support across three pandemic periods and three age groups. Mortality remained high throughout all periods, but the use of invasive respiratory support decreased over time.
A nationwide cohort of 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France. The data, managed by Santé publique France, was used to investigate factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support across the first three pandemic periods. The dataset was authored by Antoine Journé and last updated in April 2026.
Antoine Journé's dataset from 2026 contains clinical data for 15,423 critically ill COVID-19 patients admitted to intensive care units in mainland France. The data covers the first three pandemic periods from February 2020 to June 2021, analyzing factors associated with mortality, severe ARDS, ICU-free days, and need for invasive ventilatory support. The study stratified analyses by patient age groups.
Weiyuan Mai published a bibliometric analysis on figshare in 2026, examining research trends in allergic diseases and B cells over the past 20 years. The dataset includes analysis of 3,084 articles from Web of Science and 71 clinical trials from PubMed. It visualizes publication trends, keyword co-occurrence, and emerging research hotspots using CiteSpace and VOSviewer.
Oxfendazole treatment for 5 days led to a 97.6% median reduction in worm count in a preclinical mouse model. The data, published by Frederic Risch on figshare in 2026, supports the repurposing of this veterinary anthelmintic for human filarial infections. It contains results from a study investigating the drug's efficacy against the infective larval stage of Litomosoides sigmodontis.
A cross-sectional analysis of 2,543 hospitalized patients aged 60 years and older with fragility fractures. The dataset, authored by Weifeng Lv and last updated in April 2026, measures serum 25(OH)D concentrations and analyzes associations with demographic factors, comorbidities, and specific fracture sites.
A clinical trial dataset from a study of 350 participants in Mogode, Cameroon, investigating the immune response to oral cholera vaccine (OCV) booster doses. The dataset, authored by Jerome Ateudjieu and last updated in April 2026, likely contains vibriocidal antibody titer measurements from serum samples collected at baseline and multiple time points post-vaccination. Participants were stratified by age and prior vaccination history and randomized into single-dose or two-dose booster arms.
UK Renal Registry data for 10,308 primary glomerulonephritis and 8,302 ADPKD patients initiating kidney replacement therapy between 1999 and 2019, with follow-up to December 2021. The dataset, authored by Stephen A Roberts, contains survival estimates and incidence rates for end-stage kidney disease. It was last updated on 2026-04-28.
A UK Renal Registry cohort of 10,308 primary glomerulonephritis and 8,302 adult polycystic kidney disease patients initiating kidney replacement therapy between 1999 and 2019, with follow-up to December 2021. The dataset was created by Stephen A Roberts and includes incidence rates, survival outcomes by treatment modality, and demographic analysis. It was last updated on April 28, 2026.
10,308 primary glomerulonephritis and 8,302 adult polycystic kidney disease patient records from the UK Renal Registry, spanning 1999 to 2021. Stephen A Roberts authored this analysis of kidney replacement therapy incidence and survival outcomes, with data last updated in April 2026. The dataset reveals a 10-year survival rate of 81.8% after transplantation for pGN patients, compared to 37.9% on haemodialysis.